SecuritySYK / Stryker Corp. (863667101)
IndustrySurgical and Medical Instruments and Apparatus
Common Stock Shares Outstanding374,000,000 shares (as of 2018-06-30)
Total Insiders26
Total Directors12
Total Officers15

Stock Insider Trading (from SEC Form 4)

Stryker Corp. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

SYK / Stryker Corp. insiders include Floyd David, Carpenter Lonny J, Suri Rajeev PARFET WILLIAM U, BRAINERD MARY K, Sagar Bijoy, Datar Srikant, STRYKER RONDA E, Fink M Kathryn, Boehnlein Glenn S, Owen Katherine Ann, Benscoter Steven P, McCoy Sherilyn S, and Becker Yin C, Lobo Kevin, Scannell Timothy J, Golston Allan C., Subrahmanian Ramesh, FRANCESCONI LOUISE, Hutchinson Michael David, Berry William E Jr, Silvernail Andrew K, McLean Graham A, Menon Viju, COX HOWARD E JR, Doliveux Roch, .

Insider Roster

Insider Dir Off 10% Shares Owned
Doliveux Roch Director
X 19,604
BRAINERD MARY K Director
X 600
Scannell Timothy J Group President
X
Carpenter Lonny J Group President
X 104,437
Datar Srikant Director
X
Suri Rajeev Director
X
McCoy Sherilyn S Director
X
STRYKER RONDA E Director
X
Silvernail Andrew K Director
X
Golston Allan C. Director
X
FRANCESCONI LOUISE Director
X
Menon Viju Group President
X 0
Floyd David Group President
X 33,597
Owen Katherine Ann VP, Strategy and IR
X 8,607
Boehnlein Glenn S VP, Chief Financial Officer
X 4,822
COX HOWARD E JR Director
X 525,452
Sagar Bijoy VP, Chief Information Officer
X 4,854
McLean Graham A President, Asia-Pacific
X 5,670
Lobo Kevin Chairman and CEO, Director
X X 49,887
Hutchinson Michael David General Counsel
X 12,677
Fink M Kathryn VP, Chief HR Officer
X 6,382
Berry William E Jr VP, Corporate Controller
X 1,627
Becker Yin C VP, Comm. and Public Affairs
X 10,761
PARFET WILLIAM U Director
X
Subrahmanian Ramesh Group President
X
Benscoter Steven P VP, Human Resources
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-08-01 4 BRAINERD MARY K M D 600 600
2018-07-31 4 Doliveux Roch P D 165.315 44 19,604 3,240,835
2018-05-04 4 Carpenter Lonny J S X D 166.4206 -5,000 104,437 17,380,468
2018-05-01 4 Scannell Timothy J F D 169.42 -668 135,723
2018-05-01 4 Scannell Timothy J M D 1,355 136,391
2018-05-01 4 Floyd David F D 169.42 -352 33,597
2018-05-01 4 Floyd David M D 723 33,949
2018-05-01 4 Carpenter Lonny J F D 169.42 -591 109,437
2018-05-01 4 Carpenter Lonny J M D 1,355 110,028
2018-04-30 4 Doliveux Roch P D 171.2692 43 19,560 3,350,026
2018-04-18 4 Owen Katherine Ann S X D 165 -2,651 8,607 1,420,155
2018-04-16 4 Boehnlein Glenn S S X D 160 -750 4,822 771,520
2018-03-26 4 Owen Katherine Ann S X D 160 -103 11,216 1,794,560
2018-03-21 4 Golston Allan C. M D 720 9,027
2018-03-21 4 Silvernail Andrew K M D 720 1,902
2018-02-28 4 Silvernail Andrew K G D -470 1,182
2018-03-21 4 Datar Srikant M D 720 9,277
2018-03-21 4 STRYKER RONDA E M D 720 23,767,763
2018-03-21 4 Carpenter Lonny J F D -8,234 108,623
2018-03-21 4 Carpenter Lonny J A D 19,892 116,857
2018-03-22 4 Becker Yin C S X D 162.9174 -1,804 10,761 1,753,154
2018-03-22 4 Becker Yin C S X D 162.8809 -2,044 12,565 2,046,599
2018-03-21 4 Becker Yin C F D -2,041 14,609
2018-03-21 4 Becker Yin C A D 4,142 16,650
2018-03-21 4 Berry William E Jr F D 166.51 -152 1,627
2018-03-21 4 Berry William E Jr M D 531 1,779
2018-03-21 4 Berry William E Jr F D 166.51 -186 1,248
2018-03-21 4 Berry William E Jr M D 647 1,434
2018-03-21 4 Berry William E Jr F D 166.51 -177 787
2018-03-21 4 Berry William E Jr M D 618 964
2018-03-21 4 Boehnlein Glenn S F D 166.51 -313 5,528
2018-03-21 4 Boehnlein Glenn S M D 904 5,841
2018-03-21 4 Fink M Kathryn F D 166.51 -167 6,382
2018-03-21 4 Fink M Kathryn M D 582 6,549
2018-03-21 4 Floyd David F D 166.51 -10,502 33,151
2018-03-21 4 Floyd David A D 21,550 43,653
2018-03-21 4 Hutchinson Michael David F D 166.51 -2,991 12,677
2018-03-21 4 Hutchinson Michael David A D 7,182 15,668
2018-03-22 4 Lobo Kevin S X D 162.8966 -39,808 49,887 8,126,423
2018-03-21 4 Lobo Kevin F D 166.51 -39,732 89,695
2018-03-21 4 Lobo Kevin A D 80,669 129,427
2018-03-21 4 McLean Graham A M D 621 5,670
2018-03-21 4 McLean Graham A M D 609 5,049
2018-03-23 4 Owen Katherine Ann S X D 160.2311 -2,572 11,319 1,813,656
2018-03-21 4 Owen Katherine Ann F D 166.51 -3,269 13,891
2018-03-21 4 Owen Katherine Ann A D 8,728 17,160
2018-03-21 4 Sagar Bijoy F D 166.51 -1,537 4,854
2018-03-21 4 Sagar Bijoy A D 4,422 6,391
2018-03-21 4 Sagar Bijoy F D 166.51 -302 1,969
2018-03-21 4 Sagar Bijoy M D 612 2,271
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Cardiovascular Systems Posts 2-Year LIBERTY 360 Study Data

8h zacks
Cardiovascular Systems, Inc. (CSII - Free Report) recently released two-year data from its LIBERTY 360° clinical study in a late-breaking presentation at the 2018 Amputation Prevention Symposium (AMP) in Chicago. (2-0)

Wright Medical Getting Its House Back In Order

2018-08-09 seekingalpha
Efforts to return the lower extremity business to growth appear to be working a little better than expected, while the shoulder business continues to do great. (2-0)

DENTSPLY (XRAY) Beats on Q2 Earnings, Lowers 2018 Guidance

2018-08-07 zacks
DENTSPLY SIRONA Inc. (XRAY - Free Report) reported adjusted earnings per share (EPS) of 60 cents in the second quarter of 2018, beating the Zacks Consensus Estimate by a penny. However, earnings deteriorated 7.7% from the prior-year quarter. (2-0)

K2M Gets A Boost From A Stronger Spine Market

2018-08-07 seekingalpha
International growth drove better-than-expected revenue this quarter, but K2M's domestic growth showed ongoing share gains as well. (2-0)

Tracking Yacktman Asset Management Portfolio - Q2 2018 Update

2018-08-06 seekingalpha
Yacktman Asset Management decreased Twenty-First Century Fox, Microsoft, Sysco, and Cisco Systems substantially during the quarter. (114-2)